Related Experiment Videos
Monogenic renal diseases: a clinical introduction
1Université Paris V-René Descartes, Service de Néphrologie, Hôpital Necker, Paris, France. jean-pierregrunfeld@nck.ap-hop-paris.fr
Journal of Nephrology
|January 8, 2003
Summary
Research into monogenic kidney diseases is advancing, with most genes identified but clinical characterization incomplete. Future efforts focus on understanding disease variability, mechanisms, and developing treatments.
Area of Science:
- Nephrology
- Genetics
- Molecular Medicine
Background:
- Monogenic renal diseases encompass a broad spectrum, including autosomal dominant polycystic kidney disease and rare inherited conditions.
- The genetic basis for the majority of these disorders has been elucidated.
- However, several monogenic kidney diseases remain clinically uncharacterized.
Purpose of the Study:
- To highlight the current state of research in monogenic kidney diseases.
- To identify future challenges and research directions in the field.
- To emphasize the transition into the post-gene era of genetic research.
Main Methods:
- Review of existing literature on monogenic renal diseases.
- Analysis of identified genes and their associated clinical phenotypes.
- Discussion of challenges in clinical characterization and molecular understanding.
Main Results:
- Significant progress has been made in identifying genes responsible for monogenic kidney diseases.
- A gap exists in the clinical characterization of some identified monogenic renal disorders.
- The field is poised for advancements in understanding disease mechanisms and variability.
Conclusions:
- Future research must address phenotypic variability and molecular mechanisms of monogenic kidney diseases.
- Development of pharmacological interventions to slow disease progression is a key objective.
- The post-gene era offers extensive opportunities for novel research in inherited kidney disorders.